Published in Clin Exp Immunol on April 01, 1971
Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest (1974) 3.24
Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest (1976) 2.20
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol (1977) 1.57
Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest (1979) 1.49
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest (1976) 1.41
Antibody-associated lymphotoxin in acute infection. J Clin Invest (1973) 1.34
Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest (1984) 1.32
Anti-lymphocytotoxic antibodies in sera of Thai adults infected with Plasmodium falciparum or Plasmodium vivax. Clin Exp Immunol (1980) 1.31
A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. J Clin Invest (1978) 1.27
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Lymphocytotoxic antibodies in patients with systemic lupus erythematosus. Clin Exp Immunol (1974) 1.19
Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest (1979) 1.09
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest (1981) 1.00
Antibodies to beta 2 microglobulin in the sera of patients with systemic lupus erythematosus. Immunology (1977) 0.97
Serum heat-labile opsonins in systemic lupus erythematosus. J Clin Invest (1974) 0.95
Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. J Clin Invest (1979) 0.95
Cell-mediated immunity in systemic lupus erythematosus. Clin Exp Immunol (1977) 0.91
Lymphocytotoxic antibodies in systemic lupus erythematosus: evidence for reactivity with i antigen. Clin Exp Immunol (1978) 0.90
Antibodies for T lymphocytes in systemic lupus erythematosus. Clin Exp Immunol (1976) 0.87
Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique. J Clin Invest (1983) 0.85
Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.83
Relationship of phytohaemagglutinin-induced lymphocyte transformation to disease activity in systemic lupus erythematosus. Ann Rheum Dis (1976) 0.79
Immunologic studies on Werner's syndrome. Clin Exp Immunol (1980) 0.78
Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera. J Clin Invest (1980) 0.77
Lymphocytotoxins in epileptic patients receiving phenytoin. Clin Exp Immunol (1977) 0.75
Gordon Wilson lecture, 1974: Searching for the cause of systemic lupus erythematosus. Trans Am Clin Climatol Assoc (1975) 0.75
Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus. Ann Rheum Dis (1982) 0.75
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Fetomaternal leukocyte incompatibility. J Clin Invest (1958) 3.32
Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature (1970) 2.40
The distribution in the tissues and the development of H-2 antigens of the mouse. Proc Natl Acad Sci U S A (1961) 1.60
The incidence and significance of complete and incomplete white cell antibodies with special reference to the use of the Coombs consumption test. Vox Sang (1958) 1.54
Studies on leucocyte iso- and auto-antibodies. Br J Haematol (1961) 1.31
The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood (1951) 1.30
CYTOTOXIC ISO-ANTIBODIES AGAINST LEUCOCYTES. Vox Sang (1965) 1.18
Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets. Blood (1961) 1.03
[The direct antiglobulin consumption test with leukocytes and blood platelets from some patients with idiopathic pancytopenias]. Vox Sang (1958) 0.98
[Chronic leukopenia due to auto-antibodies]. Acta Haematol (1954) 0.93
Nature of the coating globulin causing a positive antiglobulin consumption test. Nature (1961) 0.92
Antisera for tissue-typing: the production of cytotoxic and agglutinating antibodies following intradermal leukocyte injections in man. Blood (1968) 0.90
Leukocyte and thromboycte antibodies. Current concepts of their origin, identity, and significance. JAMA (1962) 0.86
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97
In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest (1968) 4.01
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Lymphokine stimulation of collagen accumulation. J Clin Invest (1976) 2.94
Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest (1976) 2.84
The effect of gold salt on lysosomal enzymes of the peritoneal macrophage. Arthritis Rheum (1966) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol (1986) 2.67
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A (1980) 2.61
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
T lymphocyte adhesion to endothelial cells: mechanisms demonstrated by anti-LFA-1 monoclonal antibodies. J Immunol (1986) 2.28
Production of interleukin 1 by human endothelial cells. J Immunol (1986) 2.27
Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med (1982) 2.26
Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19
Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum (1976) 2.18
Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum (1975) 2.09
Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity. J Immunol (1973) 2.08
Immunofluorescent demonstration of an IgG-B1C complex in synovial lining cells of rheumatoid synovial membrane. Clin Exp Immunol (1969) 2.00
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Lymphokines in the rheumatoid joint. Arthritis Rheum (1975) 1.87
Time of appearance and distribution of cells capable of secondary immune response following primary immunization. Immunology (1967) 1.84
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
A new antigen system expressed in human endothelial cells. J Clin Invest (1977) 1.79
Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum (1976) 1.75
Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74
Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol (1987) 1.73
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol (1985) 1.67
Negative result: treatment of patients with rheumatoid arthritis with gamma globulin: a double-blind controlled study. Arthritis Rheum (1969) 1.63
Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med (1983) 1.57
Lymphocyte chemotactic activity of human interleukin 1. J Immunol (1984) 1.56
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Studies of isolated synovial living cells of rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum (1971) 1.49
Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46
Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed. J Lab Clin Med (1968) 1.45
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics (1998) 1.43
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum (1973) 1.41
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Effects of bacterial lipopolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol (1986) 1.41
IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum (1983) 1.39
Effect of a gold salt on the immune response. Arthritis Rheum (1967) 1.38
Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest (1979) 1.38
Viruses and the connective tissue diseases. Ann Intern Med (1971) 1.37
Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. J Clin Invest (1989) 1.36
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum (1974) 1.34
The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice. J Immunol (1982) 1.31
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum (1972) 1.31
Cold-insoluble complexes and complement levels in systemic lupus erythematosus. N Engl J Med (1969) 1.31
Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum (1986) 1.30
Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD. J Immunol (1978) 1.29
Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest (1986) 1.29
Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice. Clin Exp Immunol (1971) 1.28
Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. A comparison between adult and juvenile rheumatoid arthritis. Arthritis Rheum (1981) 1.26
Immunoglobulin classes of DNA binding activity in serum and skin in systemic lupus erythematosus. J Clin Invest (1977) 1.26
Degradation of immunoglobulins by intracellular proteases in the range of neutral pH. J Immunol (1970) 1.26
Lymphotoxin formation by lymphocytes and muscle in polymyositis. J Clin Invest (1972) 1.26
Phagocytosis of immune complexes by polymorphonuclear leucocytes in patients with Felty's syndrome. Clin Exp Immunol (1977) 1.25
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Nephrosis in the rat induced by rat kidney extracts. Ann N Y Acad Sci (1965) 1.24
The human immune response region (HLA-D) and disease susceptibility. Immunol Rev (1983) 1.24
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc (1970) 1.23
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis. Clin Exp Immunol (1973) 1.23
HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. J Immunol (1983) 1.22
Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Response of the rheumatoid synovial membrane to exogenous immunization. J Clin Invest (1971) 1.20
Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 1.20
Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol (2000) 1.18
Diet in the treatment of rheumatoid arthritis. Arthritis Rheum (1983) 1.17
Electron-dense deposits following injection of gold sodium thiomalate and thiomalic acid. Arthritis Rheum (1968) 1.16
IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum (1985) 1.15
HLA-Dw4 in adult and juvenile rheumatoid arthritis. Transplant Proc (1977) 1.15
Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers. J Immunol (1986) 1.14
Abnormal polyclonal B cell activation in NZB/NZW F1 mice. J Immunol (1977) 1.14
The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts. J Immunol (1978) 1.14
Pathways to chronic inflammation in rheumatoid synovitis. Fed Proc (1987) 1.14
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. J Clin Invest (1980) 1.13
Employment outcomes in family-aided assertive community treatment. Am J Orthopsychiatry (2000) 1.13
Immune interferon enhances the production of interleukin 1 by human endothelial cells stimulated with lipopolysaccharide. J Immunol (1986) 1.12
HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.12